Immunotherapy Archives - Page 2 of 3 - NFCR

Immunotherapy

Natural Killer (NK) Cell-based Treatment Demonstrates Its Potential to Become an Effective Novel Cancer Therapy

Natural Killer (NK) cells are specialized lymphocytes that play critical roles in the immune response against abnormal cells, including all kinds of cancer cells. Different from T cells that need to be pre-activated by antigen-presenting cells before gaining the killing power, NK cells can quickly respond to a wide variety…...

Read more

3 Important Tips For Immuno-Oncology Drug Treatment

[vc_template name=”A world without”]...

Read more

Cancer Research Applied to Develop COVID-19 Treatment Strategies

[vc_template name=”A world without”]...

Read more

Leading the Development of New Cancer Technologies: Dr. Paul Abrams’ Story

Dr. Paul Abrams has dedicated a 30-plus career spanning academia, government, non-profit, investing and business to developing new cancer therapeutics. While in medical school at Yale, Paul experienced the first of many losses to cancer when his uncle and his father’s uncle passed away from lung cancer, both within one…...

Read more

Immunotherapy: Fighting Cancer and More?

[vc_template name=”A world without”]...

Read more

Breakthrough: Dr. César Milstein And The MAbs

They are called “mAbs,” short for monoclonal antibodies, and they are a big deal in oncology. One of the immune systems most elegant soldiers, mAbs are formed by B cells, a type of white blood cell produced in the spleen, in response to specific foreign invaders (real and perceived) known…...

Read more

A Rapidly Emerging Field of Cancer Treatment

The human body normally runs like a well-oiled machine. It is able to activate muscles and run repairs without a conscious thought. One of the truly fascinating components of the human body is the immune system. The immune system is able to identify potentially harmful foreign matter and destroy it.…...

Read more